Two years ago, CRISPR gene editing pioneer Feng Zhang and former Illumina chief technology officer Alex Aravanis launched a startup to develop medicines that would change how genes are turned on and …
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
